Caroline Paternotte
University College London
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Caroline Paternotte.
American Journal of Human Genetics | 2000
Bertrand Fontaine; Claire-Sophie Davoine; Alexandra Durr; Caroline Paternotte; Imed Feki; Jean Weissenbach; Jamilé Hazan; Alexis Brice
Hereditary spastic paraplegia (HSP) comprises a group of clinically and genetically heterogeneous disorders causing progressive spasticity and weakness of the lower limbs. We report a large family of French descent with autosomal dominant pure HSP. We excluded genetic linkage to the known loci causing HSP and performed a genomewide search. We found evidence for linkage of the disorder to polymorphic markers on chromosome 2q24-q34: a maximum LOD score of 3. 03 was obtained for marker D2S2318. By comparison with families having linkage to the major locus of pure autosomal dominant HSP (SPG4 on chromosome 2p), there were significantly more patients without Babinski signs, with increased reflexes in the upper limbs, and with severe functional handicaps.
American Journal of Medical Genetics Part A | 2005
Kit Doudney; G.E. Moore; Philip Stanier; Patricia Ybot-Gonzalez; Caroline Paternotte; Nde Greene; Andrew J. Copp; Re Stevenson
To the Editor:Neural tube defects (NTD) are a heterogeneous group ofcongenitalmalformationsthataffectthebrainandspinalcord.The most severe phenotype is craniorachischisis, where thehindbrain and entire neural tube remain open. In human, itmay account for up to 10–20% of all human NTD, particularlywhen taking into account early fetal loss and therapeutictermination [Seller, 1987; Kirillova et al., 2000].Studies in Drosophila, mouse, Xenopus, and zebrafish haveindependently identified a number of genes whose productsfunction in a pathway to establish planar cell polarity (PCP).Mutationofanyofthesegenesinvertebratesresultsinanopenneuraltubeequivalenttothehumandefectcraniorachischisis.Consequently, PCP is emerging as an important biochemicalpathway for vertebrate neurulation. Through studying theLoop-tail mouse, the causitive gene Vangl2 was the first ofthe PCP genes to be identified as the cause of severe NTD[Kibar et al., 2001; Murdoch et al., 2001]. Initiation of neuraltube closure at the hindbrain–cervical boundary (Closure 1)requires the floor plate to narrow by the process of convergentextension (CE) during late gastrulation. If CE fails, the neuralfolds remain too far apart to meet and fuse [reviewed in Coppet al., 2003]. Genetic and biochemical studies have shown thatestablishment of PCP involves crucial interactions betweenmolecules such as frizzled (Fz), dishevelled (Dsh/Dvl), fla-mingo/starry night (fmi/stan/Celsr1), prickle (pk), rhoA, andstrabismus/Vangogh(Stbm/Vang)[reviewedinStrutt,2003].An added level of complexity is demonstrated by the interac-tion of the apical-basal polarity gene scribble(Scrb1), which inthe mouse mutant circletail (Crc) demonstrates a highlysimilarphenotypetobothLpandScy/Crshmutants[Murdochet al., 2003].In this study, we set out to investigate VANGL2 for a role inhuman NTD. We were also aware of a highly conservedparalogue of Vangl2 called Vangl1, which is present on mousechromosome 3qF2.2/human 1p13.1. This locus represents aduplicated block similar to the Vangl2/VANGL2 locus onmouse 1qH3/human 1q23.2. To investigate a potentiallysimilar or overlapping role for Vangl1/VANGL1 in neurula-tion, expression was first investigated using reverse tran-scriptase-PCR (RT-PCR) in both human and mouse fetaltissues (as previously described in Doudney et al., 2002).Vangl1isdetectedinwholemouseembryocDNAsspanningatleast the developmental period between E7.5 and E16.5(Fig. 1A). Human VANGL1 is widely expressed at both eightand 14 weeks gestation in all tissues investigated with theexception of placenta (Fig. 1B,C). To establish the spatial andtemporal expression of Vangl1, we performed wholemount insitu hybridization analysis of normal (þ/þ or Lp/þ) and Lp/Lpneurulation-stagemouseembryos.AtE9,Vangl1exhibiteda pattern of expression confined to the developing neural tubefrom the level of the hindbrain to the posterior neuropore(Fig. 1D,E,F, and H), with expression declining in a cranial tocaudal direction. Lp/Lp mutant embryos showed no obviousdifference in Vangl1 expression, compared to Lp/þ and wildtypeembryos(Fig.1D,E,andF).Vangl1transcriptsareabsentin all three embryos at the cardiac region, whereas Vangl2 ispresent. In comparison to Vangl2 expression, Vangl1 tran-scripts are more confined to the midline at the initiation ofClosure 1 at E8.5, and extended more caudally along the bodyaxis (compare Fig. 1G,H). Transverse sections along the bodyaxis of E9 embryos (Fig. 1D and E) showed that expression ofVangl1 is restricted to the ventral portion of the neural tube(Fig. 1I,J). In contrast to Vangl2, which at the same stage isexpressed in the flanking neuroepithelium but absent fromcells in the floor plate region [Murdoch et al., 2001], Vangl1transcripts are confined strictly to the differentiating floorplate in the cranial region (Fig. 1I–1 and 2). Interestingly, atthis level, Lp/Lp embryos showed a more diffuse expressionpattern,withVangl1expressionextendinglaterallywithinthepersistently open neural tube. More caudally, beyond the gapin expression at the cardiac level (Fig. 1I–3, J-3), expressionwas high and confined to the ventral half of the neural tube.Hence,cellsofboththefuturefloorplateandtheventro-lateralneuroepithelium express Vangl1 at these caudal levels of thebody axis. There did not appear to be any major differences inthe pattern of Vangl1 expression between Lp/þ and Lp/Lpembryos in the caudal region at E9, although the radicallydifferentneuraltubemorphology (closedinLp/þ,openinLp/Lp) might obscure subtle differences.Fromthisanalysis,weconcludethatVangl2andVangl1areco-expressed in the developing neural tube but with someimportantdifferences.MostnotablyVangl1becomesrestrictedtothefloorplateregionofthemorematureneuraltubewhichisquite different from Vangl2, which becomes specificallyexcludedfromthefloorplate,althoughitsexpressioncontinuesin non-floor plate cells of the ventral neural tube [Murdochet al.,2001].These differences may underlie theapparent lackof redundancy between the two genes, with functional Vangl1not compensating for the Vangl2 missense mutations identi-fiedintheLpmouse.ThegenerationofamouseVangl1mutantwill therefore be helpful in understanding their separate rolesin neural tube development. In contrast, comparative studiesin zebrafish show that trilobite (vangl2) and vangl1 havelargely non-overlapping expression patterns [Jessen andSolnica-Krezel, 2004]. Nevertheless, vangl1 over-expressionThis article contains supplementary material, which may beviewed at the American Journal of Medical Genetics websiteat http://www.interscience.wiley.com/jpages/1552-4825/suppmat/index.html.Grant sponsor: SPARKS; Grant sponsor: The Institute ofObstetrics and Gynaecology Trust; Grant sponsor: The Hammer-smith Hospital Trust; Grant sponsor: The Wellcome Trust.*Correspondence to: K. Doudney, Institute of Reproductive andDevelopmental Biology, Imperial College London, HammersmithHospital, Du Cane Road, London, W12 0NN, UK.E-mail: [email protected]; [email protected] 8 October 2004; Accepted 17 March 2005DOI 10.1002/ajmg.a.30766 2005 Wiley-Liss, Inc.
Molecular and Cellular Neuroscience | 2003
Jennifer N. Murdoch; Kit Doudney; Dianne Gerrelli; Noel Wortham; Caroline Paternotte; Philip Stanier; Andrew J. Copp
Igsf8 is an immunoglobulin protein that binds to the tetraspanin molecules, CD81 and CD9. We describe the genomic organization of mouse and human Igsf8, and reveal a dynamic expression pattern during embryonic and fetal development. Igsf8 is first expressed at E9.5 in a ventral domain of the neural tube, with dorsal expression apparent at E10.5. We show that the ventral, but not the dorsal, domain of neural tube expression is dependent on Shh signaling. From E11.5, Igsf8 is expressed at the lateral edge of the ventricular zone, in early postmitotic neuroblasts, and in dorsal root and cranial ganglia. Igsf8 is also expressed in the branchial arches, dorsal pancreatic primordium, neural retina, olfactory epithelium, gut, kidney, and lung.
American Journal of Medical Genetics Part A | 2005
Kit Doudney; G.E. Moore; Philip Stanier; Patricia Ybot-Gonzalez; Caroline Paternotte; Nde Greene; Andrew J. Copp; Re Stevenson
Erratum Analysis of the Planar Cell Polarity Gene Vangl2 and its Co-Expressed Paralog Vangl1 in Neural Tube Defect Patients (Am J Med Genet 136A: 90–92, 2005) K. Doudney,* G.E. Moore, P. Stanier, P. Ybot-Gonzalez, C. Paternotte, N.D.E. Greene, A.J. Copp, and R.E. Stevenson Institute of Reproductive and Developmental Biology, Imperial College London, Du Cane Road, London, United Kingdom Neural Development Unit, Institute of Child Health, University College London, 30 Guilford Street, London, United Kingdom J.C. Self Research Institute, Greenwood Genetics Center, Greenwood, South Carolina
Human Molecular Genetics | 2003
Jennifer N. Murdoch; Deborah J. Henderson; Kit Doudney; Carles Gaston-Massuet; Helen M. Phillips; Caroline Paternotte; Ruth M. Arkell; Philip Stanier; Andrew J. Copp
Human Molecular Genetics | 2001
Jennifer N. Murdoch; Kit Doudney; Caroline Paternotte; Andrew J. Copp; Philip Stanier
Genomics | 2002
Kit Doudney; Jennifer N. Murdoch; Claire Braybrook; Caroline Paternotte; Louise Bentley; Andrew J. Copp; Philip Stanier
Genomics | 2001
Kit Doudney; Jennifer N. Murdoch; Caroline Paternotte; Louise Bentley; Simon G. Gregory; Andrew J. Copp; Philip Stanier
Genomics | 1999
Jamilé Hazan; Claire-Sophie Davoine; Delphine Mavel; Nuria Fonknechten; Caroline Paternotte; Corinne Cruaud; Delphine Samson; Delphine Muselet; Nathalie Vega-Czarny; Alexis Brice; Gabor Gyapay; Roland Heilig; Bertrand Fontaine; Jean Weissenbach
In: (pp. A15-A15). (2001) | 2001
Caroline Paternotte; Jennifer N. Murdoch; Kit Doudney; Philip Stanier; Andrew J. Copp